SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRIS, Curis (formerly CBMI)
CRIS 1.170+8.3%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lhn5 who wrote (182)11/16/1998 1:35:00 PM
From: Harold Engstrom  Read Replies (1) of 668
 
Newly assigned CBM patent:

U.S. Patents via NewsEdge Corporation : Abstract: Disclosed are (1) nucleic acid sequences, amino acid sequences, homologies, structural features and various other data characterizing a morphogen cell surface receptor;(2)methods for producing receptor proteins, including fragments thereof, using recombinant DNA technology; (3) methods for identifying novel morphogen receptors and their encoding DNAs; (4) methods for identifying compounds capable of modulating endogenous morphogen receptor levels; and (5)methods for identifying morphogen receptor binding analogsuseful in the design of morphogen agonists and antagonistsfor therapeutic, diagnostic and experimental uses.

Ex Claim Text: An isolated nucleic acid fragment comprising:(a) the coding nucleotide sequence defined by SEQ ID NO: 1;or(b) the nucleotide sequence encoding the amino acid sequenceof SEQ ID NO: 2 or conservative amino acid substitutionsthereof.

Patent Number: 5831050

Issue Date: 1998 11 03
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News